A Cyclodextrin‐Based pH‐Responsive MicroRNA Delivery Platform Targeting Polarization of M1 to M2 Macrophages for Sepsis Therapy
Advanced Healthcare Materials · 2023-10 · 12 (27)
DOI: 10.1002/adhm.202301243 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 27.07.2023. Verfasst von Ni Ding und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518107, China. Hauptthemen laut MEDLINE: MicroRNAs, Cyclodextrins, Sepsis. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shenzhen Fundamental Research Program, Shenzhen Science and Technology Innovation Program.
Themen: Sepsis
Abstract (Originalsprache)
The mortality rate of sepsis remains high despite improvements in the diagnosis and treatment of sepsis using symptomatic and supportive therapies, such as anti‐infection therapy and fluid resuscitation. Nucleic acid‐based drugs have therapeutic potential, although their poor stability and low delivery efficiency have hindered their widespread use. Herein, it is confirmed that miR‐223 can polarize proinflammation M1 macrophages to anti‐inflammation M2 macrophages. A pH‐sensitive nano‐drug delivery system comprising β‐cyclodextrin‐poly(2‐(diisopropylamino)ethyl methacrylate)/distearoyl phosphoethanolamine‐polyethylene glycol (β‐CD‐PDPA/DSPE‐PEG) is synthesized and developed to target M1 macrophages and miR‐223 is encapsulated into nanoparticles (NPs) for sepsis treatment. NPs/miR‐223 demonstrated in vitro pH responsiveness with favorable biosafety, stability, and high delivery efficiency. In vivo studies demonstrate that NPs/miR‐223 are preferentially accumulated and retained in the inflammation site, thereby reducing inflammation and improving the survival rate of mice with sepsis while exhibiting ideal biosafety. Mechanically, NPs/miR‐223 regulates macrophage polarization by targeting Pknox1 and inhibiting the activation of the NF‐κB signaling pathway, thereby achieving an anti‐inflammatory effect. Collectively, it is demonstrated that the miRNA delivery vector described here provides a new approach for sepsis treatment and accelerates the advancement of nucleic acid drug therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anaesthesiology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518107, China.
- Scientific Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518107, China.
- Department of Anesthesiology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China.
- Department of Anesthesiology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
- College of Chemistry and Materials Science, Sichuan Normal University, Chengdu, 610068, China.
ORCID-Profile: Yang Kang
Förderung
- National Natural Science Foundation of China
- Shenzhen Fundamental Research Program
- Shenzhen Science and Technology Innovation Program
Zitieren
APA
Ding, N., Luo, G., Li, H., Xing, C., Gao, Y., Xi, W., Wu, W., Wang, D., Zheng, L., Kang, Y., & Chi, X. (2023). A Cyclodextrin‐Based pH‐Responsive MicroRNA Delivery Platform Targeting Polarization of M1 to M2 Macrophages for Sepsis Therapy. Advanced Healthcare Materials, 12(27). https://doi.org/10.1002/adhm.202301243
Vancouver
Ding N, Luo G, Li H, Xing C, Gao Y, Xi W, et al. A Cyclodextrin‐Based pH‐Responsive MicroRNA Delivery Platform Targeting Polarization of M1 to M2 Macrophages for Sepsis Therapy. Advanced Healthcare Materials. 2023;12(27). doi:10.1002/adhm.202301243
BibTeX
@article{Ding2023,
author = {Ding, Ni and Luo, Gangjian and Li, Huiting and Xing, Chengyuan and Gao, Yuanji and Xi, Wenjie and Wu, Weijie and Wang, Dan and Zheng, Lei and Kang, Yang and Chi, Xinjin},
title = {A Cyclodextrin‐Based pH‐Responsive MicroRNA Delivery Platform Targeting Polarization of M1 to M2 Macrophages for Sepsis Therapy},
journal = {Advanced Healthcare Materials},
year = {2023},
volume = {12},
number = {27},
doi = {10.1002/adhm.202301243}
}
EUVIMED